CytomX Therapeutics Inc
F:6C1
CytomX Therapeutics Inc
F:6C1
Price:
2.998
EUR
-0.93%
Market Closed
Market Cap:
€233.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CytomX Therapeutics Inc
F:6C1
|
US |
|
I
|
IGas Energy PLC
OTC:IGESF
|
UK |
Wall St Price Targets
6C1 Price Targets Summary
CytomX Therapeutics Inc
CytomX Therapeutics Inc
Wall Street analysts forecast 6C1 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 6C1 is 11.516 EUR with a low forecast of 5.442 EUR and a high forecast of 15.087 EUR.
Lowest Forecast
Price Target
5.442
EUR
82% Upside
Average Forecast
Price Target
11.516
EUR
284% Upside
Highest Forecast
Price Target
15.087
EUR
403% Upside
CytomX Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6C1's stock price target?
Price Target
11.516
EUR
11.516
EUR
According to Wall Street analysts, the average 1-year price target for 6C1 is 11.516 EUR with a low forecast of 5.442 EUR and a high forecast of 15.087 EUR.
What is the Revenue forecast for CytomX Therapeutics Inc?
Projected CAGR
28%
28%
Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 28%.
